Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
CYT-101 by Cyteph for Astrocytoma: Likelihood of Approval
CYT-101 is under clinical development by Cyteph and currently in Phase II for Astrocytoma. According to GlobalData, Phase II drugs...
Data Insights
CYT-101 by Cyteph for Recurrent Glioblastoma Multiforme (GBM): Likelihood of Approval
CYT-101 is under clinical development by Cyteph and currently in Phase II for Recurrent Glioblastoma Multiforme (GBM). According to GlobalData,...